Pennsylvania has granted 23 new retail licenses for the second stage of its medical marijuana program; among the winners were a few public companies in the space.

On Tuesday (December 18), the Pennsylvania Department of Health confirmed the new cannabis licenses had been granted, allowing the winners to go operational within the next six months.


Among the public companies awarded licenses were Cresco Labs (CSE:CL), Harvest Health & Recreation (CSE:HARV), MedMen Enterprises (CSE:MMEN) and Green Thumb Industries (CSE:GTII).

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

MedMen secured its spot on the list by way of its blockbuster all-stock acquisition of PharmaCann for a price of US$682 million.

Harvest was awarded six licenses, one in each area indicated by the Pennsylvania Department of Health. Right next to it was GTI, which won four licenses total. PharmaCann got two licenses and Cresco obtained only one in the state.

Each license awarded grants the companies the option to open three marijuana dispensaries.

During the phase one stage of the retail rollout in June 2017, GTI and Cresco had already secured one retail license each.

This week GTI had also secured new licenses for retail operations in New Jersey.

Steve White, founder and CEO of Harvest, said in a statement to shareholders Pennsylvania had exceeded their expectations as a cannabis market, adding it has risen as one of the most important states for the company’s operations.

Similar to its neighboring state of New Jersey, the Pennsylvania Department of Health has divided different sections for companies to apply and gain licenses.

However, unlike New Jersey, Pennsylvania didn’t block the same company from obtaining multiple licenses in different areas.

Pennsylvania secretary of health Dr. Rachel Levine said the phase of two of the dispensary rollout will give more options to consumers.

“This step continues the growth of our scientific, medically-based medical marijuana program,” Dr. Levine said.

According to the local government agency, once all these new dispensaries are open, Pennsylvania will have 79 total shops.

Pennsylvania has over 98,000 patients who have registered for the state medical marijuana program, with over 66,000 currently owning identification cards making them available to purchase legal product.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less